Rare Disease Day marks a global moment of reflection and resolve.

More than 300 million people worldwide live with a rare condition. Many are children. Many face delayed diagnosis. For most rare diseases, approved therapeutic options remain limited or non-existent.
While scientific innovation continues to accelerate, translation into accessible treatment remains uneven. Rare disease is not a marginal issue, it is a structural healthcare challenge requiring coordinated action across science, clinical delivery, regulation and capital.

At Ambrose Healthcare, we believe the next phase of rare disease progress must move beyond awareness toward disciplined execution.